KFF Health News Southern correspondent Sam Whitehead discussed vaccine exemptions on WAMU’s “Health Hub” on Jan. 22. Whitehead also discussed major Georgia health stories of 2025 on WUGA’s “The Georgia Health Report” on Jan. 17. Click here to hear Whitehead on “Health Hub” Click here to hear Whitehead on “The Georgia Health Report” Read Whitehead’s…
Solera Health has launched a behavioral health network that connects members to partners Calm Health and Lyra Health for digital mental health, coaching and therapy services. The post Solera Health Launches Behavioral Health Network with Calm and Lyra appeared first on MedCity News.
Triumphant music plays as cancer patients go camping, do some gardening, and watch fireworks in ads for Opdivo+Yervoy, a combination of immunotherapies to treat metastatic melanoma and lung cancer. Ads for Skyrizi, a medicine to treat plaque psoriasis and other illnesses, show patients snorkeling and riding bikes — flashing their rash-free elbows. People with Type…
When doctors told her they had to remove her tongue and voice box to save her life from the cancer that had invaded her mouth, Sonya Sotinsky sat down with a microphone to record herself saying the things she would never again be able to say. “Happy birthday” and “I’m proud of you” topped the…
It reduced cravings, dulled alcohol’s “buzz,” and carried no risk of addiction. By every measure, naltrexone should have immediately become a major triumph. Instead, it flopped because the institutions charged with treating addiction refused to use it. Now considered a gold standard, it survived because patients and communities kept it alive. The post The Pill Patients…
Nebraska is the first state to announce it plans to begin enforcing Medicaid work requirements early, starting May 1, 2026. Initial reports from the state during its recent January Medicaid Advisory Committee (MAC) meeting and data from KFF’s Medicaid work requirements tracker provide early insights into how Nebraska is preparing for implementation.
With the global market for anti-obesity drugs projected to hit $95 billion by 2030, it’s no surprise that compounded semaglutide is gaining traction as a cheaper, more accessible option. But for all its appeal, this route comes with real risks: regulatory uncertainty, legal exposure, and major insurance hurdles. The post Protecting Your Biotech: Understanding the Risks…
To be clear, this doesn’t mean healthcare organizations should adopt LLMs tomorrow. But what’s changed is that the primary obstacle – cost at scale – is no longer the immovable obstacle it once was. For healthcare leaders who have been watching the AI wave from the sidelines, this is the moment to move from curiosity…
This analysis provides data on women experiencing intimate partner violence (IPV) and reports on a range of health topics affecting women who experienced IPV in the past five years, including their health care needs and use, barriers, and mental health.
Hinge Health is poised to go public, 23andMe has filed for bankruptcy, and the importance of data sharing are the focus of the latest episode of the Debunked podcast with MedCity News Editor-in-Chief Arundhati Parmar and Samir Batra, managing partner of Health Innovation Pitch. The post Debunked Episode 14: Is This a Good Time for…